Pharmaceutical Products of India Ltd


BSE: 524113 | NSE: PPIL | ISIN: NA 
Market Cap: [Rs.Cr.] 5 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

 Discuss this stock

Auditor's Report

Pharmaceutical Products Of India Ltd. Date: 2002.12.31. Auditor's report AUDITORS' REPORT FOR THE YEAR ENDED 31ST DECEMBER, 2002. We have audited the attached Balance Sheet of THE PHARMACEUTICAL PRODUCTS OF INDIA LIMITED as at 31st December, 2002 and the annexed Profit & Loss Account of the Company for the year ended on that date and report that: 1. We have obtained all information and explanations which to the best of our knowledge and belief were necessary for the purpose of our audit. 2. In our opinion proper books of accounts as required by law have been kept by the Company as far as it appears from our examination of these books. 3. The Balance Sheet and Profit &.Loss Account dealt with by this report are in agreement with the books of accounts and are, subject to Note 10 & Note 11 in respect of loans & advances and in respect of non-provision of interest,'in compliance with the Accounting Standards prescribed under Section 211 (3C) of the Companies Act, 1956. 4. In our opinion and to the best of our information and according to the explanation given to us the said accounts read together with the notes thereon,give the information required by the companies Act, 1956, in the manner so required and give a true and fair view, subject to Note 10 & Note 11 to respect of non-provision of interest and loans & advances, . i) In the case of the Profit and Loss Account, of the Loss for the year ended on 31st December, 2002 and ii.) In the case of the Balance Sheet of the Company's affairs as at 31st December, 2002 5. Further as required by the Manufacturing and Other Companies (Auditors Report) Order, 1988, issued by the Central Government in terms of Section 227 (4A) of the Companies Act,1956, and on the basis of such checks as we considered appropriate, we report that: i) As explained to us the records of quantitative details and situation of fixed assets are being updated. These.fixed assets have been physically verified by the management at reasonable intervals and no material discrepancies were noticed on such verification. ii) In respect 'of finished goods, stores & spares and raw materials other than stocks lying with third .parties, physically verification has been conducted by the management at reasonable intervals: iii) The procedure of physical verification of stocks followed by the management are reasonable and adequate in relation to the size of the company and the nature of its business. iv) The discrepancies noticed on physical verification of stocks as compared to book records which were not material, have been properly dealt with in the books of accounts. v) On the basis of our examination and in our opinion, the valuation of stock is fair and proper in accordance with the normally accepted accounting principles and is on the same basis as in the preceding year and effect has been given in the accounts in respect of decline in values of the stocks. vi) The Company has not taken any loans from companies, firms and other parties listed in the register maintained under Section 301 of the Companies Act, 1956, or from companies under the same management as defined under 370 (1 B) of the companies Act, 1956. vii) In respect of loans and advances in the nature of loans given by the Company, the amounts are being recovered regularly. viii) The company has not granted any loans and advances in the nature of loans to companies, firms and other parties listed in the register maintained u/s 301 of the Companies Act , 1956 or to Companies under the same management as defined under section 370(1B) of the Companies Act, 1956. ix) In our opinion and according to the information given to us, there are adequate internal control procedures commensurate with the size of the Company and the nature of the business with regard to purchase of stores, raw materials including components, plant and machinery, equipments and other assets and for the sale of goods. x) The Company has not made purchase of goods in excees of Rs. 50,000 in value from companies in which Directors are interested as listed in the register maintained under Section 301 of the Companies Act, 1956. xi) Unserviceble or damaged stores, raw materials and finished goods are determined and provision for loss, if any, has been made in the accounts. xii) In our opinion and according to the explanation given to us, the Company has not complied with Section 58A of the Companies Act, 1956 and rules framed thereunder specifically in respect of non-maintenance of liquid assets and in respect of repayment of deposits. xiii) In our opinion, reasonable records have been maintained commensurate with the size and nature of its business. xiv) In our opinion, the Company has an internal audit system commensurate with the size and nature of its business. xv) The Company is not maintaining cost records under Section 209 (1) (d) of the Companies Act, 1956. xvi) The Company has been generally regular in depositing Provident Fund dues with appropriate authorities. xvii) There were undisputed amounts in respect of Customs Duty, Excise Duty, Income-tax & Sales tax as at 31st December, 2002 which were outstanding for more than six months. xviii) As per explanations given to us, personal expenses have not been charged to revenue accounts other than those payable under contractual obligations or in accordance with generally accepted business practices. xix) The Company is a sick Industrial Company within the meaning of Clause (0) of the subsection (1) of Section 3 of the Sick Industrial Companies (special Provisions) Act, 1985 and as such, reference has been made to the Board for Industrial & Financial Reconstruction. xx.) In respect of the Company's trading activities, damaged goods have been determined and necessary provision for loss, if any has been made in the accounts.

Related News

 
No Related News

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds. 100,567.12 194.61 12.91 27.45 26.1 27.0 0.01
Dr Reddy's Labs 36,245.70 28.64 4.76 18.79 14.3 16.6 0.25
Cipla 30,490.13 20.23 3.44 14.11 15.9 19.8 0.03
Cadila Health. 15,951.29 34.19 5.54 18.45 28.4 24.2 0.40
Glenmark Pharma. 15,579.46 40.36 6.17 23.94 12.7 11.7 0.39
Ranbaxy Labs. 14,910.04 0.00 7.76 72.87 0.0 0.0 2.38
Wockhardt 12,193.51 33.10 14.90 12.82 237.0 30.3 2.09
Piramal Enterp. 9,667.98 0.00 0.92 23.66 0.8 2.1 0.07
Ipca Labs. 8,639.02 26.07 5.50 10.09 24.2 23.7 0.49
Torrent Pharma. 6,978.19 12.11 4.23 11.66 29.6 25.5 0.48
Biocon 5,510.00 19.21 2.50 12.20 12.6 13.6 0.08
Aurobindo Pharma 5,278.00 10.64 1.80 22.89 10.7 8.8 1.01
Strides Arcolab 4,987.36 34.00 3.64 46.94 7.3 8.9 0.56
Mylan Lab. 3,273.19 6.80 1.77 0.00 26.9 26.1 0.59
Alembic Pharma 2,493.86 15.84 5.42 5.60 39.5 27.7 1.07

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Pradeep U Patil , Director 

Shashi Nambiar , Director 

Sudarshan Mohatta , Nominee (IDBI) 

Sunil V Kotyankar , Director 


Company Head Office / Quarters:
Plot No D-312 TTC Indl Area,
MIDC,
Navi Mumbai,
Maharashtra-400705
Phone : 91-022-5230870
Fax : 91-022-5230880/8508574
E-mail :
Web : http://
Registrars:
Sharex Dynamic (India) Pvt Ltd
Unit No 1 Luthra Ind
Andheri Kurla Road
Safed Pool Andheri(E
Mumbai - 400 072

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

Jun-2013
M T W T F S S
17 18 19 20 21 22 23
IPO
listNo IPO today
Economic Events
list Foreign Buying Japan Bonds (Yen)
list Foreign Buying Japan Stocks (Yen)
Results
list Coromandel Inter